AIRLINK 191.00 Decreased By ▼ -5.65 (-2.87%)
BOP 10.15 Increased By ▲ 0.01 (0.1%)
CNERGY 6.75 Increased By ▲ 0.06 (0.9%)
FCCL 34.35 Increased By ▲ 1.33 (4.03%)
FFL 17.42 Increased By ▲ 0.77 (4.62%)
FLYNG 23.80 Increased By ▲ 1.35 (6.01%)
HUBC 126.30 Decreased By ▼ -0.99 (-0.78%)
HUMNL 13.80 Decreased By ▼ -0.10 (-0.72%)
KEL 4.75 Decreased By ▼ -0.01 (-0.21%)
KOSM 6.55 Increased By ▲ 0.18 (2.83%)
MLCF 43.35 Increased By ▲ 1.13 (2.68%)
OGDC 226.45 Increased By ▲ 13.42 (6.3%)
PACE 7.35 Increased By ▲ 0.34 (4.85%)
PAEL 41.96 Increased By ▲ 1.09 (2.67%)
PIAHCLA 17.24 Increased By ▲ 0.42 (2.5%)
PIBTL 8.45 Increased By ▲ 0.16 (1.93%)
POWER 9.05 Increased By ▲ 0.23 (2.61%)
PPL 194.30 Increased By ▲ 10.73 (5.85%)
PRL 37.50 Decreased By ▼ -0.77 (-2.01%)
PTC 24.05 Decreased By ▼ -0.02 (-0.08%)
SEARL 94.97 Decreased By ▼ -0.14 (-0.15%)
SILK 1.00 No Change ▼ 0.00 (0%)
SSGC 40.00 Decreased By ▼ -0.31 (-0.77%)
SYM 17.80 Decreased By ▼ -0.41 (-2.25%)
TELE 8.72 Decreased By ▼ -0.01 (-0.11%)
TPLP 12.46 Increased By ▲ 0.25 (2.05%)
TRG 62.74 Decreased By ▼ -1.62 (-2.52%)
WAVESAPP 10.35 Decreased By ▼ -0.09 (-0.86%)
WTL 1.73 Decreased By ▼ -0.06 (-3.35%)
YOUW 4.02 Increased By ▲ 0.02 (0.5%)
BR100 11,814 Increased By 90.4 (0.77%)
BR30 36,234 Increased By 874.6 (2.47%)
KSE100 113,247 Increased By 609 (0.54%)
KSE30 35,712 Increased By 253.6 (0.72%)
Pakistan

Russia offers Sputnik V COVID-19 vaccine to Pakistan

  • Ministry of Foreign Affairs received a letter to this effect along with data on the vaccine’s clinical research and trials from the Russian Embassy in Islamabad
  • Although, Sputnik V has not finished its final trials, Russia started distributing vaccinations last week
Published December 9, 2020

(Karachi) As struggle to get coronavirus vaccine gains momentum globally, Russia has offered to supply its Sputnik V COVID-19 vaccine to Pakistan, local media reported. Although, Sputnik V has not finished its final trials, the country started distributing vaccinations last week.

As per details, the Ministry of Foreign Affairs received a letter to this effect along with data on the vaccine’s clinical research and trials from the Russian Embassy in Islamabad.

The Foreign Ministry has sent the vaccine offer to the National Health Services (NHS) for further process.

Vaccine developed by Russia proved to be 92 percent effective in preventing coronavirus, the interim results showed. Russia registered Sputnik V for public use in August, the first country to do so, though the approval came before the start of the large-scale trial in September.

The Phase III trial of the shot developed by the Gamaleya Institute took place in 29 clinics across Moscow and involved 40,000 volunteers in total. The chances of contracting COVID-19 were 92% lower among people vaccinated with Sputnik V, the Russian Direct Investment Fund stated.

Comments

Comments are closed.